A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.

作者: Hubert Pakula , Dongxi Xiang , Zhe Li

DOI: 10.3390/CANCERS9020014

关键词:

摘要: Prostate cancer (PCa) is one of the most common cancers and among leading causes deaths for men in industrialized countries. It has long been recognized that prostate an androgen-dependent organ PCa disease. Androgen action mediated by androgen receptor (AR). deprivation therapy (ADT) standard treatment metastatic PCa. However, almost all advanced cases progress to castration-resistant (CRPC) after a period ADT. A variety mechanisms progression from CRPC under ADT have postulated, but it remains largely unclear as when how castration resistance arises within tumors. In addition, AR signaling may be modulated extracellular factors which are cysteine-rich glycoproteins WNTs. The WNTs capable through several pathways, best-characterized being canonical WNT/β-catenin/TCF-mediated pathway. Recent studies sequencing genomes revealed cells frequently harbor mutations major components WNT/β-catenin Moreover, finding interaction between β-catenin suggests possible mechanism cross talk WNT androgen/AR pathways. this review, we discuss current knowledge both pathways development tumorigenesis, their during CRPC. We also review therapeutic application drugs target Finally, extend our mammary gland system breast cancer. highlight role its with these two hormone-related types highly context-dependent.

参考文章(330)
B. J. Kennedy, SYSTEMIC EFFECTS OF ANDROGENIC AND ESTROGENIC HORMONES IN ADVANCED BREAST CANCER Journal of the American Geriatrics Society. ,vol. 13, pp. 230- 235 ,(1965) , 10.1111/J.1532-5415.1965.TB02670.X
Frauke Drees, Sabine Pokutta, Soichiro Yamada, W. James Nelson, William I. Weis, α-Catenin Is a Molecular Switch that Binds E-Cadherin-β-Catenin and Regulates Actin-Filament Assembly Cell. ,vol. 123, pp. 903- 915 ,(2005) , 10.1016/J.CELL.2005.09.021
Gerald R. Cunha, Mesenchymal–epithelial interactions: past, present, and future Differentiation. ,vol. 76, pp. 578- 586 ,(2008) , 10.1111/J.1432-0436.2008.00290.X
Jeff Holzbeierlein, Priti Lal, Eva LaTulippe, Alex Smith, Jaya Satagopan, Liying Zhang, Charles Ryan, Steve Smith, Howard Scher, Peter Scardino, Victor Reuter, William L. Gerald, Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance American Journal of Pathology. ,vol. 164, pp. 217- 227 ,(2004) , 10.1016/S0002-9440(10)63112-4
H Yamamoto, N Oue, A Sato, Y Hasegawa, H Yamamoto, A Matsubara, W Yasui, A Kikuchi, Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene. ,vol. 29, pp. 2036- 2046 ,(2010) , 10.1038/ONC.2009.496
Michael T Veeman, Jeffrey D Axelrod, Randall T Moon, A Second Canon Developmental Cell. ,vol. 5, pp. 367- 377 ,(2003) , 10.1016/S1534-5807(03)00266-1
E. Lee, A. Madar, G. David, M. J. Garabedian, R. DasGupta, S. K. Logan, Inhibition of androgen receptor and β-catenin activity in prostate cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 15710- 15715 ,(2013) , 10.1073/PNAS.1218168110
Gary Davidson, Wei Wu, Jinlong Shen, Josipa Bilic, Ursula Fenger, Peter Stannek, Andrei Glinka, Christof Niehrs, Casein kinase 1γ couples Wnt receptor activation to cytoplasmic signal transduction Nature. ,vol. 438, pp. 867- 872 ,(2005) , 10.1038/NATURE04170
Stephen J. Weber-Hall, Deborah J. Phippard, Christina C. Niemeyer, Trevor C. Dale, Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland Differentiation. ,vol. 57, pp. 205- 214 ,(1994) , 10.1046/J.1432-0436.1994.5730205.X
Olga Kazanskaya, Andrei Glinka, Ivan del Barco Barrantes, Peter Stannek, Christof Niehrs, Wei Wu, R-Spondin2 Is a Secreted Activator of Wnt/β-Catenin Signaling and Is Required for Xenopus Myogenesis Developmental Cell. ,vol. 7, pp. 525- 534 ,(2004) , 10.1016/J.DEVCEL.2004.07.019